E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 10/30/2020 in the Prospect News Emerging Markets Daily.

China Resources Pharma to sell RMB 1 billion 3.79% perpetual bonds

By Taylor Fox

New York, Oct. 30 – China Resources Pharmaceutical Group Ltd.’s wholly owned subsidiary, China Resources Pharmaceutical Holdings Co. Ltd., plans to sell RMB 1 billion of perpetual bonds with a coupon of 3.79%, according to a company announcement.

The bonds have an initial term of two years but may be extended for another two years or repaid in full at the end of every two-year period.

Proceeds will be used to repay debt.

The pharmaceutical company has offices in Hong Kong and Beijing.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.